Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Broughton

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|April 21, 2001
New selective cytotoxic diterpenylquinones and diterpenylhydroquinonesJ M Miguel Del Corral, M Gordaliza, M A Castro, et al.
Biochemistry|August 16, 1994
Structural analysis of inositol monophosphatase complexes with substratesR Bone, L Frank, J P Springer, et al.
Journal of Medicinal Chemistry|August 1, 1997
5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.
Journal of Medicinal Chemistry|July 18, 1997
4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptorM Rowley, I Collins, H B Broughton, et al.
Journal of Medicinal Chemistry|December 10, 1999
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonistsM G Russell, V G Matassa, R R Pengilley, et al.
Journal of Medicinal Chemistry|May 10, 1996
3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptorJ J Kulagowski, H B Broughton, N R Curtis, et al.
Journal of Medicinal Chemistry|September 23, 2000
Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonistsC M Low, J W Black, H B Broughton, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
Journal of Medicinal Chemistry|June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profilesM B van Niel, I Collins, M S Beer, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Medicinal Chemistry|April 21, 2001
New selective cytotoxic diterpenylquinones and diterpenylhydroquinonesJ M Miguel Del Corral, M Gordaliza, M A Castro, et al.
Biochemistry|August 16, 1994
Structural analysis of inositol monophosphatase complexes with substratesR Bone, L Frank, J P Springer, et al.
Journal of Medicinal Chemistry|August 1, 1997
5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.
Journal of Medicinal Chemistry|July 18, 1997
4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptorM Rowley, I Collins, H B Broughton, et al.
Journal of Medicinal Chemistry|December 10, 1999
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonistsM G Russell, V G Matassa, R R Pengilley, et al.
Journal of Medicinal Chemistry|May 10, 1996
3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptorJ J Kulagowski, H B Broughton, N R Curtis, et al.
Journal of Medicinal Chemistry|September 23, 2000
Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonistsC M Low, J W Black, H B Broughton, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
Journal of Medicinal Chemistry|June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profilesM B van Niel, I Collins, M S Beer, et al.
Pageof 2